SecBot SecBot
6-K ·Filed May 12, 2026

RDY

DR REDDYS LABORATORIES LTD
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago SEC0001575872-26-000303
Notable filing: 6-K
Actionable Insight • Neutral

The filing lacks extractable financial data. Monitor for a subsequent press release or analyst call for actual Q4 results and forward guidance.

DirectionNeutral
Confidencelow
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$12.99
T+0 close · May 12, 2026 · via day close
Latest settled
−5.93%
T+60 · $12.22
Vs SPY
−10.37%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 13 $12.99entry
  2. T+1 · 6mo ago 0.00%α +0.00% · $12.99
  3. T+5 · 6mo ago +3.54%α +4.70% · $13.45
  4. T+20 · 5mo ago +2.85%α +3.46% · $13.36
  5. T+60 · 3mo ago −5.93%α −10.37% · $12.22
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dr. Reddy's Laboratories filed its Q4 FY26 audited financial results presentation via a 6-K on May 12, 2026. The filing is a routine earnings disclosure with no specific financial figures or guidance provided in the document text, making the material impact unclear.

Key Facts

  • Filed Q4 FY26 audited financial results presentation under Regulation 30 of SEBI Listing Regulations
  • Filing date: May 12, 2026
  • No specific financial figures (revenue, EPS, margins) or guidance were disclosed in the filing text
  • Document content consists of a cover letter and graphic images of the presentation, not extractable text

Financial Impact

No financial figures available in the filing text

Risk Factors

  • No quantitative data to assess performance
  • Potential for negative surprise if results are weak

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
50% bullish (44 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001575872-26-000303
Document: 0001575872-26-000303-index.html0001575872-26-000303
Document: 0001575872-26-000303.txt0001575872-26-000303

Track record

73 reports on RDY

Performance horizon

7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
  2. Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
  3. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
  4. Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
  5. Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
  6. Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
  7. Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  8. Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  9. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
  10. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
Showing 10 of 73

US Market Status

Market Closed · Opens in 5h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 12, 2026